金鴻藥業(yè)股份有限公司，股票代碼：831186，新三板掛牌企業(yè)，成立于2005年4月，注冊資本6560萬元，是一家集藥品研發(fā)、生產(chǎn)與銷售為一體的現(xiàn)代化制藥企業(yè)，產(chǎn)品涵蓋醫(yī)藥中間體、原料藥和制劑。金鴻藥業(yè)以滿足患者健康需求為己任，奉行“至善、勤勉、簡潔”的經(jīng)營理念，努力建成國際化的品牌制藥企業(yè)。
金鴻藥業(yè)現(xiàn)有金海岸和定家灣兩個生產(chǎn)園區(qū)，占地面積分別為31,670 m2和53,450 m2。金鴻藥業(yè)現(xiàn)有13個車間25條生產(chǎn)線和29項專利。在藥品研發(fā)、生產(chǎn)與質(zhì)量控制方面，金鴻藥業(yè)一直保持著高標準的質(zhì)量管理水平。所有藥品上市均經(jīng)過主管機構(gòu)審評，藥品的生產(chǎn)嚴格按照現(xiàn)行GMP要求，從而保證藥品的安全性、質(zhì)量和有效性。
Kinhoo Pharmaceutical Co., Ltd., stock code: 831186, as a NEEQ listed enterprise, found in April 2005 with a registered capital of RMB 65.6 million. Kinhoo is a modernized pharmaceutical enterprise integrating pharmaceutical R&D, production and sales, engaged with medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations. To meet health needs of patients, Kinhoo holds the business philosophy of “Perfection, Diligence, Concision”, and strives for building an international brand pharmaceutical enterprise.
Kinhoo has two Manufacturing Sites, Golden Coast bio-industrial park and Dingjia Bay international medical ecological park, covering an area of 31,670 m2 and 53,450 m2 respectively. Kinhoo has 13 workshops with 25 production lines and 29 patents. Kinhoo maintains high standards of Quality Management in the development, manufacture and control of medicinal products. All medicinal products are assessed by the competent authority to get marketing authorizations, the manufacture of medicinal products has strictly taken place in accordance with guidelines for current Good Manufacturing Practice, to ensure compliance with contemporary requirements of safety, quality and efficacy.
